Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan.
We conducted a multicenter retrospective cohort study across 38 hospitals in Chiba, Japan, between February 1, 2020 and November 31, 2021 to investigate the effect of coronavirus disease 2019 (COVID-19) on patients with diabetes mellitus receiving inpatient care. We collected inpatient medical data...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319801 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849337467394588672 |
|---|---|
| author | Hirotsugu Suwanai Masato Kanda Kazuharu Harada Keitaro Ishii Hajime Iwasaki Natsuko Hara Yoshio Kobayashi Hajime Matsumura Takahiro Inoue Ryo Suzuki |
| author_facet | Hirotsugu Suwanai Masato Kanda Kazuharu Harada Keitaro Ishii Hajime Iwasaki Natsuko Hara Yoshio Kobayashi Hajime Matsumura Takahiro Inoue Ryo Suzuki |
| author_sort | Hirotsugu Suwanai |
| collection | DOAJ |
| description | We conducted a multicenter retrospective cohort study across 38 hospitals in Chiba, Japan, between February 1, 2020 and November 31, 2021 to investigate the effect of coronavirus disease 2019 (COVID-19) on patients with diabetes mellitus receiving inpatient care. We collected inpatient medical data through Diagnosis procedure combination (DPC), the diagnoses and payment system of medical insurance, from each hospital. We excluded patients younger than 18 years, those who were pregnant, and those who had diabetes but were not treated with diabetic medication. A total of 10,776 patients were included: 7,679 in the non-diabetic (control) group and 3,097 in the diabetic group. Patients in the diabetic group were older and had a higher body mass index (BMI) than those in the control group. In the diabetes group, 88.4% of the patients were treated with insulin therapy and 44.2% were treated with oral hypoglycemic agents. The length of hospital days was significantly longer in the diabetes group. The in-hospital mortality rate was significantly higher especially between 50 and 59 years old. The rates of in-hospital mortality, mechanical ventilation, intensive care unit (ICU) admission, renal replacement therapies such as hemodialysis (HD), and continuous hemodiafiltration (CHDF) were all higher, even after adjusting for age, sex, BMI, and ambulance use. In conclusion, diabetes was a significant risk factor of the severe clinical outcomes especially for in-hospital mortality, mechanical ventilation usage, ICU admission, HD, and CHDF in Japan. |
| format | Article |
| id | doaj-art-0745649697d7457eb12209bea901b1d1 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-0745649697d7457eb12209bea901b1d12025-08-20T03:44:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01203e031980110.1371/journal.pone.0319801Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan.Hirotsugu SuwanaiMasato KandaKazuharu HaradaKeitaro IshiiHajime IwasakiNatsuko HaraYoshio KobayashiHajime MatsumuraTakahiro InoueRyo SuzukiWe conducted a multicenter retrospective cohort study across 38 hospitals in Chiba, Japan, between February 1, 2020 and November 31, 2021 to investigate the effect of coronavirus disease 2019 (COVID-19) on patients with diabetes mellitus receiving inpatient care. We collected inpatient medical data through Diagnosis procedure combination (DPC), the diagnoses and payment system of medical insurance, from each hospital. We excluded patients younger than 18 years, those who were pregnant, and those who had diabetes but were not treated with diabetic medication. A total of 10,776 patients were included: 7,679 in the non-diabetic (control) group and 3,097 in the diabetic group. Patients in the diabetic group were older and had a higher body mass index (BMI) than those in the control group. In the diabetes group, 88.4% of the patients were treated with insulin therapy and 44.2% were treated with oral hypoglycemic agents. The length of hospital days was significantly longer in the diabetes group. The in-hospital mortality rate was significantly higher especially between 50 and 59 years old. The rates of in-hospital mortality, mechanical ventilation, intensive care unit (ICU) admission, renal replacement therapies such as hemodialysis (HD), and continuous hemodiafiltration (CHDF) were all higher, even after adjusting for age, sex, BMI, and ambulance use. In conclusion, diabetes was a significant risk factor of the severe clinical outcomes especially for in-hospital mortality, mechanical ventilation usage, ICU admission, HD, and CHDF in Japan.https://doi.org/10.1371/journal.pone.0319801 |
| spellingShingle | Hirotsugu Suwanai Masato Kanda Kazuharu Harada Keitaro Ishii Hajime Iwasaki Natsuko Hara Yoshio Kobayashi Hajime Matsumura Takahiro Inoue Ryo Suzuki Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan. PLoS ONE |
| title | Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan. |
| title_full | Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan. |
| title_fullStr | Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan. |
| title_full_unstemmed | Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan. |
| title_short | Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan. |
| title_sort | diabetes with covid 19 was a significant risk factor for mortality mechanical ventilation and renal replacement therapies a multicenter retrospective study in japan |
| url | https://doi.org/10.1371/journal.pone.0319801 |
| work_keys_str_mv | AT hirotsugusuwanai diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT masatokanda diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT kazuharuharada diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT keitaroishii diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT hajimeiwasaki diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT natsukohara diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT yoshiokobayashi diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT hajimematsumura diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT takahiroinoue diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan AT ryosuzuki diabeteswithcovid19wasasignificantriskfactorformortalitymechanicalventilationandrenalreplacementtherapiesamulticenterretrospectivestudyinjapan |